Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Sales | 56 | 26 | 46 | 0 | 0 |
| Cost of Goods | 21 | 10 | 21 | N/A | N/A |
| Gross Profit | 35 | 16 | 25 | N/A | N/A |
| Operating Expenses | 3,635 | 3,791 | 2,991 | 3,271 | 2,528 |
| Operating Income | -3,579 | -3,766 | -2,946 | -3,271 | -2,528 |
| Other Income | 66 | 65 | 77 | 78 | 49 |
| Pre-tax Income | -3,514 | -3,701 | -2,868 | -3,193 | -2,479 |
| Net Income Continuous | -3,514 | -3,701 | -2,868 | -3,193 | -2,479 |
| Net Income | $-3,514 | $-3,701 | $-2,868 | $-3,193 | $-2,479 |
| EPS Basic Total Ops | -0.07 | -0.07 | -0.06 | -0.06 | -0.05 |
| EPS Basic Continuous Ops | -0.07 | -0.07 | -0.06 | -0.06 | -0.04 |
| EPS Diluted Total Ops | -0.07 | -0.07 | -0.06 | -0.06 | -0.05 |
| EPS Diluted Continuous Ops | -0.07 | -0.07 | -0.06 | -0.06 | -0.04 |
| EBITDA(a) | $-3,528 | $-3,722 | $-2,885 | $-3,221 | $-2,489 |